Students and staff

8,000 respondents already included in the GISTAR study

For five years now in Latvia has been taking place the GISTAR study - a study by the Institute of Clinical and Preventive Medicine of the University of Latvia, in collaboration with the International Agency for Research on Cancer, on the potential for reducing mortality from stomach and intestinal cancer. We are proud to announce that the total number of respondents included in the study has reached 8,000 today!

From October 2013, when the GISTAR study was launched in Cesis, so far it has been taking place in such cities as Aluksne, Ludza, Saldus, Tukums, Dobele and Madona. There is a positive trend - the number of respondents included in each subsequent research center is increasing. For comparison, 761 respondents were included in the regional center of Cēsis, Ludza - 1018, Saldus - 1077. Currently, the research center in Rezekne (since April 2017) is active, which already includes 2,096 respondents.
The research supervisor is LU KPMI Director, professor of the University of Latvia, gastroenterologist Marcis Leja.
In parallel, research opportunities are being discussed in other cities of Latvia.
The inclusion of respondents in the study continues.

Share

Back